Summary & Overview
CPT 51020: Bladder Cystotomy/Cystostomy with Fulguration or Intravesical Therapy
CPT code 51020 identifies surgical entry into the urinary bladder (cystotomy or cystostomy) followed by destruction of abnormal intravesical tissue via fulguration, intravesical radioactive material, or both. This procedure is clinically significant for management of bladder lesions that require direct access and ablation, and it carries implications for operating-room resource use, postoperative care, and device/radiation handling protocols. Nationally, the code is relevant to hospital surgical services, urology specialty care, and radiopharmaceutical management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for CPT code 51020, benchmarks and coverage patterns from major payers where available, and notes on coding considerations that affect billing and claims adjudication. The publication also contextualizes typical sites of service and service type to aid operational planning.
This summary is intended for administrators, billing professionals, and clinician leaders seeking a concise reference on the clinical and administrative characteristics of CPT code 51020. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 51020 describes a surgical procedure in which the provider makes an incision into the urinary bladder (cystotomy) or creates an opening in the bladder wall (cystostomy) to access abnormal tissue. The abnormal tissue is then destroyed by fulguration (application of high-frequency current), intravesical placement of a radioactive substance, or both.
Service type: Surgical procedure — bladder access with tissue destruction
Typical site of service: Operating room or procedural suite for open or surgical cystotomy/cystostomy with ablative therapy. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 72-year-old male with a history of recurrent non‑muscle invasive bladder cancer presents with visible hematuria and cystoscopic confirmation of multiple small papillary tumors on the bladder mucosa. The urologist schedules the patient for a cystotomy/cystostomy with fulguration and intravesical radioactive agent placement. The procedure is performed in an outpatient ambulatory surgery center under general or regional anesthesia. The surgeon makes a limited cystotomy to access the bladder lumen, resects or fulgurates superficial tumors with electrocautery, and places a radioactive implant or instills a radioactive solution for local tumor destruction before closing the bladder incision. Typical perioperative workflow includes preoperative evaluation, anesthesia consent, sterile cystotomy, tumor fulguration and/or radiotherapeutic instillation, hemostasis, bladder closure, short recovery in PACU, and discharge with catheter management and oncology follow‑up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, and/or complexity of the cystotomy/cystostomy with fulguration or intravesical radiotherapy substantially exceeds the typical service. |
52 | Reduced services |